A carregar...
Patterns of mutations in TP53 mutated AML
TP53 mutated acute myeloid leukemia (AML) responds poorly to chemotherapy and has a short overall survival rate with a median of 5–9 months. Poor outcomes in TP53 mutated AML following chemotherapy have been observed and treatment options remain limited, although the presence of TP53 mutations alone...
Na minha lista:
| Publicado no: | Best Pract Res Clin Haematol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6482955/ https://ncbi.nlm.nih.gov/pubmed/30466751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2018.09.010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|